Patients with chronic myeloid leukemia (CML) carry the BCR/ABL fusion protein (De Klein et al., 1982; Shtivelman et al., 1985). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.